Hypertension

RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial
 by George L. Bakris, MD; Manish Saxena, MBBS; Anil Gupta, MD; et al. JAMA February 16, 2024

RNAi With Zilebesiran for Hypertension, Timing of IV Thrombolysis Before Thrombectomy for Stroke, Cardiac Amyloidosis Review, and  more.
 by JAMA March 5, 2024

Chronic Thromboembolic Pulmonary Hypertension
 by Rodolfo A. Estrada, MD, William R. Auger, MD, and Sandeep Sahay, MD, MSc  JAMA February 26, 2024

RNA Interference With Zilebesiran for Mild to Moderate Hypertension The KARDIA-1 Randomized Clinical Trial
 by George L. Bakris, MD,  Manish Saxena, MBBS, Anil Gupta, MD, et al JAMA February 16m 2024 

RNA Injection Every 6 Months to Improve Adherence and Lower Blood Pressure in Patients With Hypertension
 by  Ernesto L. Schifrin, MD, PhD JAMA February 16, 2024

More Evidence That Hypertension Treatment Decisions Shouldn’t Depend Solely on In-Office Blood Pressure Readings
 by Rita Rubin, MA JAMA April 24, 2023

Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs
 by Johan Sundström, MD, PhD JAMA April 11, 2023

Is Personalized Antihypertensive Drug Selection Feasible?
 by Robert M. Carey, MD JAMA April 13, 2023

Endovascular Ultrasound Renal Denervation to Treat Hypertension
 by Michel Azizi, MD, PhD; Manish Saxena, MBBS, MSc; Yale Wang, MD5; et al JAMA February 28, 2023